An isolated polypeptide

Priyank Shukla (Inventor)

Research output: Patent


The present invention relates to an isolated polypeptide that finds utility in generating an immune response against a virus in a subject. Also disclosed are immunogenic compositions comprising the isolated polypeptide, generating an immune response against a virus in a subject, and preventing or treating a viral infection in a subject, in particular a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Original languageEnglish
Patent numberWO2022180163A1
IPCA61K 39/12 2006.1,A61P 31/14 2006.1,C07K 14/005 2006.1,C07K 14/165 2006.1
Priority date24/02/21
Filing date24/02/22
Publication statusPublished online - 1 Sept 2022


  • SARS-CoV-2
  • Covid-19
  • Covid
  • Immunoinformatics
  • Bioinformatics
  • Peptide
  • Vaccine


Dive into the research topics of 'An isolated polypeptide'. Together they form a unique fingerprint.

Cite this